Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Company Overview More
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginase inhibitor that has completed Phase 1b clinical trial for the treatment of cystic fibrosis and chronic airway infection; and ATG-037, an orally-bioavailable small molecule inhibitor of CD73, as well as CB-668, an orally administered inhibitor of the enzyme IL4I1. The company has a license agreement with Mars, Inc. to develop and commercialize Symbioscience’s portfolio of arginase inhibitors for use in human healthcare. It also has clinical trial collaboration with Pfizer to evaluate Pfizer’s PARP inhibitor talazoparib and CDK4/6 inhibitor palbociclib, each in combination with telaglenasta. In addition, the company has a collaboration and license agreement with Incyte Corporation for the research, development, and commercialization of INCB001158, a small molecule arginase inhibitor for the treatment of hematology and oncology; and a license agreement with Antengene Corporation Ltd. for the development and commercialization of CB-708. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
CEO: Molineaux Ph.D., Susan M.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist

CALA Calithera Biosciences

Watchlist
0.232+0.024+11.49%
Close 05/20 20:00 ET
0.228-0.0037-1.59%
Post Mkt Price 05/20 19:51 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
0.235
Open
0.210
Turnover
477.58K
Low
0.205
Pre Close
0.208
Volume
2.16M
Market Cap
22.55M
P/E(TTM)
Loss
52wk High
2.593
Shares
97.24M
P/E(Static)
Loss
52wk Low
0.154
Float Cap
19.15M
Bid/Ask %
66.67%
Historical High
33.480
Shs Float
82.57M
Volume Ratio
0.32
Historical Low
0.154
Dividend TTM
--
Div Yield TTM
1400
P/B
-7.25
Dividend LFY
--
Div Yield LFY
603708.49%
Turnover Ratio
2.61%
Amplitude
14.40%
Avg Price
0.221
Lot Size
1
Float Cap
19.15M
Bid/Ask %
66.67%
Historical High
33.480
Shs Float
82.57M
Volume Ratio
0.32
Historical Low
0.154
Dividend TTM
--
P/B
-7.25
Dividend LFY
--
Turnover Ratio
2.61%
Amplitude
14.40%
Avg Price
0.221
Lot Size
1
Price Forecast

No Data

News

Comment

Back to the Top